Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 39Active not recruiting 6Unknown 4Recruiting 3Withdrawn 2Terminated 2

Sponsor Class

OTHER 69INDUSTRY 26NIH 3NETWORK 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 17Gynecologic 15Breast 14Thoracic 13Lymphoid 13Sarcoma 10Head & Neck 10Other hematologic neoplasm 9CNS 9Genitourinary 8Dermatologic 5Endocrine 3Other solid neoplasm 2Myeloid 2Tumor-Agnostic 1Plasma cell 1Other 1

Conditions

Myeloproliferative Syndrome, Transient 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1

Interventions

Saline Solution 1Observation 1Fibroblast Growth Factor 7 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × NETWORK × Myeloid × Clear all
NCT00411281 2015-09-30

Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder

Children's Oncology Group

Phase 3 Withdrawn
MyeloidOther hematologic neoplasm

Myeloproliferative Syndrome, Transient, Leukemia, Leukemia, Myeloid, Acute

NCT00570999 2012-05-10

KGF Haplo Allo

European Society for Blood and Marrow Transplantation

Phase 2 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡